ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 992,87
0,18%
Dow Jones
38 686,32
1,51%
DAX
18 497,94
-0,09%
Brent Oil
81,295
0,00%
Bitcoin
67 590,88
0,16%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Moderna Inc (MRNA)

  7. Moderna Inc (MRNA) Actualités

MRNA

Moderna (MRNA)

Moderna Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:MRNA
DateHeureSourceTitreSymboleSociété
30/05/202422h36Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MRNAModerna Inc
29/05/202421h22Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:MRNAModerna Inc
29/05/202413h34IH Market NewsRobinhood Shares Surge 3.3% on Stock Buyback Announcement; Anglo Declines BHP Deadline Extension, and More NewsNASDAQ:MRNAModerna Inc
23/05/202413h40IH Market NewsOpenAI and News Corp Seal Partnership, DuPont de Nemours Announces Division, and More NewsNASDAQ:MRNAModerna Inc
09/05/202413h53IH Market NewsBain Capital in Talks to Acquire PowerSchool; Blackstone Emerges Victorious in Hipgnosis Bidding War, and More NewsNASDAQ:MRNAModerna Inc
24/04/202413h28IH Market NewsCoca-Cola and Microsoft Sign Billion-Dollar Agreement, Apple Event Set for May 7, and More NewsNASDAQ:MRNAModerna Inc
10/04/202413h13IH Market NewsDelta Generates US$37 Million Profit in Q1, Google and Intel Unveil Cutting-Edge AI Chips, and More NewsNASDAQ:MRNAModerna Inc
11/03/202421h08Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:MRNAModerna Inc
27/02/202415h14IH Market NewsU.S. Stocks May Lack Direction Following Yesterday’s Modest PullbackNASDAQ:MRNAModerna Inc
23/02/202422h21Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:MRNAModerna Inc
22/02/202412h32Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MRNAModerna Inc
22/02/202412h05IH Market NewsU.S. Futures Surge on Nvidia’s Stellar Performance, Global Markets Respond PositivelyNASDAQ:MRNAModerna Inc
14/02/202401h07AllPennyStocks.comThe Power of Execution: Why Investors Reward Companies Who Walk the WalkNASDAQ:MRNAModerna Inc
09/01/202412h12IH Market NewsWall Street Highlights: HPE and Juniper Networks in Negotiations, Elliott Invests $1 Billion in Match Group, and MoreNASDAQ:MRNAModerna Inc
03/01/202411h41IH Market NewsWall Street Highlights: Tesla’s Competition with BYD, JPMorgan Stocks Achieve New Records, and MoreNASDAQ:MRNAModerna Inc
14/12/202321h26Dow Jones NewsTrending: Moderna Shares Rise on Favorable Skin Cancer Study ResultsNASDAQ:MRNAModerna Inc
14/12/202313h00PR Newswire (US)First In Vivo CAR-M Lead Candidate Nominated Under Carisma-Moderna CollaborationNASDAQ:MRNAModerna Inc
13/12/202314h31Dow Jones NewsModerna Shares, Other Covid Vaccine Makers Hit by Warning From PfizerNASDAQ:MRNAModerna Inc
13/12/202312h30IH Market NewsCal-Maine Avian Flu Outbreak Impact, Amgen Hikes Dividend For Twelfth Year, and Latest UpdatesNASDAQ:MRNAModerna Inc
11/12/202313h41Dow Jones NewsMerck, Moderna Expand Phase 3 Keytruda/V940 Combo WorkNASDAQ:MRNAModerna Inc
11/12/202312h45Business WireMerck and Moderna Initiate INTerpath-002, a Phase 3 Study Evaluating V940 (mRNA-4157) in Combination with KEYTRUDA® (pembrolizumab) for Adjuvant Treatment of Patients with Certain Types of Resected Non-Small Cell Lung CancerNASDAQ:MRNAModerna Inc
28/11/202301h01PR Newswire (US)Flagship Pioneering Marks Official Opening of UK Hub with Event Convening Life Science LeadersNASDAQ:MRNAModerna Inc
21/11/202312h00PR Newswire (US)Flagship Pioneering Unveils Quotient Therapeutics to Create Transformative Medicines Informed by a New Frontier of GeneticsNASDAQ:MRNAModerna Inc
03/11/202321h02Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:MRNAModerna Inc
03/11/202312h32IH Market NewsFriday’s Wall Street Highlights: Apple, Bill Holdings, Paramount, Block, and moreNASDAQ:MRNAModerna Inc
03/11/202300h14KR Market News뉴욕 증시는 미 금리 인상 종료 기대와 강한 실적에 랠리NASDAQ:MRNAModerna Inc
01/11/202315h30PR Newswire (US)Flagship Pioneering Launches Pioneering IntelligenceNASDAQ:MRNAModerna Inc
24/10/202312h30PR Newswire (US)Caris Life Sciences and Moderna Announce Multi-Year Strategic Partnership to Advance mRNA-Based Oncology TherapeuticsNASDAQ:MRNAModerna Inc
17/10/202313h37IH Market NewsTuesday’s Wall Street Highlights: Snap, Ericsson, NetScout Systems, Baidu, and moreNASDAQ:MRNAModerna Inc
16/10/202315h01IH Market NewsKeep An Eye Out: Pre-Market Movers And Analyst RecommendationsNASDAQ:MRNAModerna Inc
 Showing the most relevant articles for your search:NASDAQ:MRNA

Dernières Valeurs Consultées

TSX
TOR.SB.B
City of Toronto
BIT
F16530
Vontobel Financial Produ...
BOV
MOSC34M
Mosaic
COIN
LONUST
LON Token [Tokenlon]
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés